Semaglutide is the key component of weight loss and diabetes drugs like Ozempic and Wegovy, and an international team of ...

Our partnership with federal agencies like the FBI is a key part of our strategy to disrupt drug trafficking operations.' ...

How can policy makers and health care leaders ensure affordable, equitable access to GLP-1 medications while managing their ...

An examination of recent litigation under the Employee Retirement Income Security Act of 1974 (ERISA) challenging allegedly ...

Look out for the key nutrients. When in doubt, try to prioritize foods with fiber and complex carbs, protein, and healthy ...

LLY has delivered impressive returns of 15% year-to-date, outperforming the S&P 500’s 5% decline during the same period. This ...

Numerous studies have suggested the cultivation of cells derived from intestinal organoids as two-dimensional (2D) monolayers ...

The apparent success — and now almost ever-present ubiquity — of GLP-1 receptor agonists in weight loss has led to research, and possible uses, far beyond its initial indications in diabetes, ...

Trump-era crackdowns are forcing gangs like Tren de Aragua to flee the U.S. through the Northern border and exploit Canada’s ...

Regulus Therapeutics will be acquired by Novartis AG for $7 per share in cash. Click here for more information on RGLS ...

Traditional biochemical methods of studying human gene mutations are often laborious and costly. Now bioengineers at the ...

In this week’s edition of InnovationRx, we look at a patent fight over the world’s top-selling drug, breakthroughs from the ...